Mainz Biomed NV MYNZ

Buzz on the Bullboards: A challenging week for the TSX amid investor caution

[Jonathon Brown]

The TSX faced challenges as investors remained cautious, bracing for the upcoming US inflation data to gauge the Federal Reserve’s stance. read article.

[BlackBear22]

Could be a good start today. Investors taking positions for the New Year. BB

[BlackBear22]

Hopefully now that tax loss selling will soon be over, the shares will have an opportunity to reset and start looking ahead into future milestones the company needs to hit. Cash shouldn't be a

[BlackBear22]

for a stock that only has about 2 Mil O/S shares, to have 660,000 shares change hands in one session is pretty amaing.  Certainly has attractewd the day traders.

[BlackBear22]

Kicking myself for not averaging down.  Time will tell if it was a wise decision. Prospects looking up.

[PressRelease]

Quest to Support Mainz Biomed’s ReconAAsense FDA Study and Has Option to Commercialize Test Kit Assuming FDA Approval BERKELEY, Calif. and MAINZ, Germany, Dec. 19, 2024 (GLOBE NEWSWIRE) -- Mainz Biomed N.V. (NASDAQ:MYNZ) (“Mainz Biomed” or the “Company”), a molecular genetics diagnostic company...read article.

[PressRelease]

BERKELEY, Calif. and MAINZ, Germany, Dec. 16, 2024 (GLOBE NEWSWIRE) -- Mainz Biomed N.V. (NASDAQ:MYNZ) (“Mainz Biomed” or the “Company”), a molecular genetics diagnostic company specializing in the early detection of cancer, today announced the closing of its previously announced follow-on...read article.

[PressRelease]

BERKELEY, Calif. and MAINZ, Germany, Dec. 12, 2024 (GLOBE NEWSWIRE) -- Mainz Biomed N.V. (NASDAQ:MYNZ) (“Mainz Biomed” or the “Company”), a molecular genetics diagnostic company specializing in the early detection of cancer, today announced the pricing of a follow-on offering of 1,367,521 units...read article.

[BlackBear22]

A good bounce but we'll see if it sticks. Could be a decent takeover candidate for a bigger player at these levels. BB

[BlackBear22]

Interesting how the price was driven down on light volume following the reverse split.  Not a convincing move, but one that would certainly scare out weak hands. A strong move up on larger volume

[SkyProfit12]

MYNZ just played a smart hand with their 1-for-40 reverse split. This isn’t a desperation move; it’s a recalibration designed to attract bigger money and keep the Nasdaq spot secure. The cleaner

[BlackBear22]

This move was essential if MYNZ intended to stay listed on the Nasdaq.  It will also open some investment with companies that don't invest in stocks that are less than $3.

[SmartBull65]

Bed Bath & Beyond’s trading volume is surging, with whispers of restructuring fueling speculation. A 15% bounce is possible if investors see progress on this front. It’s a high-risk, high-reward

[PressRelease]

BERKELEY, Calif. and MAINZ, Germany, Nov. 29, 2024 (GLOBE NEWSWIRE) -- Mainz Biomed N.V. (NASDAQ:MYNZ) (“Mainz Biomed” or the “Company”), a molecular genetics diagnostic company specializing in the early detection of cancer, today announced a 1-for-40 reverse stock split of its issued and...read article.

[Vic2Trader1]

Goooo long today! 10K on MYNZ, target $0.3, and 5K on VCIG, target $6. buuuuulls, let’s ride this wave!

[500wedge]

This is a pure pump-nothing more. if it's so great why is a group pumping this BS across multible boards? Trolling for bag holders in play here...........